mohammad estiri
translational medicine at space medicine b.v at space medicine
Gather verified email addresses & phone numbers directly from LinkedIn
svp, translational medicine
Professional Email
che****@seattlegenetics.com
Personal Email
che****@gmail.com
Work Phone
(206) 794*****
Mobile
(206) 794*****
Local Location
south san francisco, california, united states
HQ Location
south san francisco, california, united states
Industry
biotechnology, health
Designation
svp, translational medicine
Birthday
-
Gender
male
HQ Location
south san francisco, california, united states
Industry
pharmaceutical manufacturing
Employees
31
Founded
2015
Specialties
Get access to potential B2B prospects and get their contact information of LinkedIn using our Sales fuel Chrome Extension.
GET EXTENSION
Install the Sales Fuel chrome extension from the Web Store. Sign up using your email address.
The Extension will sync with your LinkedIn from where you can discover in-depth Prospects' profiles, company information and Find Similar details.
Get detailed insights of Prospects Company Profile, Email ID, Phone Number, Location or Similar Designation and much more.
1
5y 8m
5y 8m
Number of Companies Worked For
Average Duration at a Single Company
Years of Professional Experience
translational medicine at space medicine b.v at space medicine
svp, research and translational medicine at synchronicity pharmaceuticals
director, translational medicine at askbio
translational medicine expert at novartis institutes for biomedical research (nibr)
manager of accounting at harpoon therapeutics
biotechnology, finance
union city, california, united states
senior ap accountant at harpoon therapeutics
wireless, finance
san francisco, california, united states
project team lead at harpoon therapeutics
biotechnology
san francisco, california, united states
clinical resarch consultant at harpoon therapeutics
pharmaceuticals, health
el paso, texas, united states
scientist in translational medicine at harpoon therapeutics
pharmaceuticals, health
san francisco, california, united states
che-leung law is currently employed at Harpoon therapeutics. che-leung is an experienced professional working at harpoon therapeutics as the svp, translational medicine. che-leungs phone number is (206) 794***** and email is che****@seattlegenetics.com to get more information install Sales fuel extension.
che-leung law is currently employed at Harpoon therapeutics.
At present, che-leung law is serving as the svp, translational medicine.
The professional email used by che-leung law is che****@seattlegenetics.com.
che-leung law's professional contact number is (206) 794*****.
Immunology, clinical development, biotechnology, cancer, drug discovery, life sciences, molecular oncology, monoclonal antibodies, biomarker discovery, antibodies, assay development, cell culture, molecular biology, biochemistry, protein chemistry, pharmaceutical industry, protein purification, drug development, biomarkers, biopharmaceuticals, cell biology, cell, flow cytometry, lifesciences, in vivo, elisa, pcr, oncology, protein expression, translational research, tissue culture, western blotting are some of the skills that che-leung law has.
Ulysses Murillo, Kathleen Ng, Shawn Melley, Holly Peterson are some of the colleagues working with che-leung law.
Mohammad Estiri, Laura Nocito, Jamie Cope, Lisa Aimone are some of the other counterparts holding the similar designation in other organizations like che-leung law.
che-leung law has worked for harpoon therapeuticsfalse so far.
According to the Harpoon therapeutics Summary, Harpoon Therapeutics is a clinical-stage immuno-oncology company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. T cell engagers are engineered proteins that direct a patient’s own T cells to kill target cells that express specific proteins, or antigens, carried by the target cells. Using its proprietary Tri-specific T cell Activating Construct (TriTAC®) platform, Harpoon is developing a pipeline of novel TriTACs initially focused on the treatment of solid tumors and hematologic malignancies. Harpoon has also developed a proprietary ProTriTAC™ platform, which applies a prodrug concept to its TriTAC platform to create a therapeutic T cell engager that remains inactive until it reaches the tumor. Harpoon’s third proprietary technology platform, extended release TriTAC-XR, is designed to mitigate cytokine release syndrome. For more information, please visit www.harpoontx.com..
The company is headquartered at South san francisco, California, United states.
che-leung law is svp, translational medicine at Harpoon therapeutics.
che-leung law is currently residing in south san francisco, california, united states.
che-leung law is currently working with the biotechnology, health industry.
Nearly 31 is the total headcount of the company.